stavudine has been researched along with Weight Loss in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atté, EF; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R | 1 |
Boulle, A; Meintjes, G; Osler, M; Rebe, K; Stead, D | 1 |
Mugabo, J; Reid, T; van Griensven, J; Zachariah, R | 1 |
Bergersen, BM; Bruun, JN; Ellingsen, I; Sandvik, L | 1 |
Mascolini, M | 1 |
5 other study(ies) available for stavudine and Weight Loss
Article | Year |
---|---|
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Organophosphonates; Rwanda; Stavudine; Tenofovir; Treatment Outcome; Weight Loss; Zidovudine | 2009 |
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Anti-HIV Agents; Developing Countries; Drug Administration Schedule; Epidemiologic Methods; Female; Humans; Lactic Acid; Male; Overweight; Peripheral Nervous System Diseases; Pregnancy; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Weight Loss | 2010 |
Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Medication Adherence; Rwanda; Stavudine; Viral Load; Weight Loss | 2010 |
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.
Topics: Adipose Tissue; Anti-HIV Agents; Blood Pressure; Body Composition; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cohort Studies; Diet; Exercise; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertension; Hypolipidemic Agents; Male; Risk Factors; Sex Factors; Stavudine; Time Factors; Triglycerides; Weight Loss | 2005 |
Winnipeg conference. What do the numbers mean?
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; AIDS Vaccines; AIDS-Related Opportunistic Infections; Antigens, Viral; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cytomegalovirus; Drug Therapy, Combination; Female; Gonorrhea; HIV Infections; HIV-1; Humans; Interleukin-2; Male; Mycobacterium; Papanicolaou Test; Patient Care Team; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Rectal Diseases; RNA, Viral; Species Specificity; Stavudine; Vaginal Smears; Weight Loss | 1995 |